Sandeep Laumas

Sandeep Laumas has filed trades across 2 companies (mainly through SEC (Form 4)), most often in 9 Meters Biopharma, Inc. and Instil Bio, Inc. We count 21 filings; the first trade dates from 28 August 2018 and the latest from 10 September 2025.

The open-market side counts 16 purchases for €34k alongside 2 sales for €600k. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 option exercises. In 2025 alone, the filings show no purchases and 2 sales.

The median purchase comes to €2,246. 14 out of 15 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

On 12 September 2025 came the latest disclosure, an option exercise for €141k in Instil Bio, Inc. The last purchase on record was published on 1 July 2019, which is 2,672 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.